跳至主要内容
临床试验/ACTRN12619000138189
ACTRN12619000138189已完成未知

Testing light therapy of changing wavelength in adults suffering from sleep disorders to improve sleep quality, day time alertness, sleep wake patterns, mood and cognition.

Woolcock Institute of Medical Research0 个研究点目标入组 12 人开始时间: 2019年1月30日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
50 Years 至 o limit(—)
性别
All

入选标准

  • 1. Able to give informed written consent
  • 2. Fluent English speaker
  • 3. Older than 50 years without cognititve impairment (based on a Mini Mental State Examination (MMSE) with a score >24)
  • 4. Subjective reported poor sleep quality (Pittsburgh Sleep Quality Index global score or PSQI greater than 5).
  • 5. Insomnia severity index (ISI) less than or equal to 15 indicating no clinically significant or subthreshold insomnia
  • 6. Multivariable apnoea prediction index (MAPI) less than or equal to 0.5 indicating low probability of being diagnosed with obstructive sleep apnoea (OSA) and/or an Apnoea-Hypopnea Index (AHI) of less than or equal to 15 indicating no or mild obstructive sleep apnoea.

排除标准

  • 1. Pregnancy or lactation
  • 2. Circadian rhythm disorders
  • 3. People highly dependent on medical care
  • 4. Shift-workers
  • 5. Recent overseas travel (<1month, >2 time-zones)
  • 6. Major psychiatric illnesses
  • 7. Sleep disorders including obstructive sleep apnoea, restless legs syndrome

研究者

相似试验

ight to improve sleep, cognition, mood and day time... | 临床试验